COVID-19 Immunologic Antiviral Therapy With Omalizumab (CIAO)—a Randomized Controlled Clinical Trial.
Saved in:
| Title: | COVID-19 Immunologic Antiviral Therapy With Omalizumab (CIAO)—a Randomized Controlled Clinical Trial. |
|---|---|
| Authors: | Le, Michelle1 (AUTHOR) elena.netchiporouk@mcgill.ca, Khoury, Lauren2 (AUTHOR), Lu, Yang3 (AUTHOR), Prosty, Connor2 (AUTHOR), Cormier, Maxime4 (AUTHOR), Cheng, Mathew P5 (AUTHOR), Fowler, Robert6 (AUTHOR), Murthy, Srinivas7 (AUTHOR), Tsang, Jennifer L Y8 (AUTHOR), Ben-Shoshan, Moshe9 (AUTHOR), Rahme, Elham3 (AUTHOR), Golchi, Shirin3 (AUTHOR), Dendukuri, Nandini3 (AUTHOR), Lee, Todd C5 (AUTHOR), Netchiporouk, Elena1 (AUTHOR) elena.netchiporouk@mcgill.ca |
| Source: | Open Forum Infectious Diseases. Apr2024, Vol. 11 Issue 4, p1-8. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
